Dendrite Buys Optas for $12 Million

Share this article:
Dendrite International Inc., a provider of sales, marketing and clinical solutions for the pharmaceutical industry, said yesterday that it has acquired Optas Inc. for $12 million.


Founded in 1997, Optas is a privacy-safe database marketing software and services company serving the pharmaceutical and health industries. Optas will become a division of Dendrite International, which is based in Bedminster, NJ.


Dendrite and Optas are already deployed together in a large pharmaceutical company where Optas enables physicians to direct patients into an educational program, and Dendrite provides a personalized patient medical support center where patients speak to medical professionals who complement and support the prescribing doctor's own initiatives. Both elements are orchestrated through Optas' campaign management tool.


Share this article:
You must be a registered member of Direct Marketing News to post a comment.
close

Next Article in Data/Analytics

Sign up to our newsletters

Follow us on Twitter @dmnews

Latest Jobs:

Featured Listings

More in Data/Analytics

MeritDirect Opens San Jose Office

MeritDirect Opens San Jose Office

A force in direct mail, the company looks to expand its digital data services with a footprint in Silicon Valley.

Neustar Decides to Hand Data Over to its Clients

Neustar Decides to Hand Data Over to its ...

AK Media Insights Pro turns data over to marketers to create business-specific aggregations, integrate offline efforts, and probe deeper into their sales funnels.

Arthur Hughes, Who Wrote the Book on Database Marketing, Dies at 86

Arthur Hughes, Who Wrote the Book on Database ...

First published in the early days of the Web, Arthur Middleton Hughes's Strategic Database Marketing remains a bible for direct marketers.